Biltmore Family Office’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.33M Sell
20,990
-186
-0.9% -$43.3K 0.7% 33
2026
Q1
$5.18M Sell
21,176
-178
-0.8% -$41.5K 0.72% 29
2025
Q4
$4.42M Buy
21,354
+1,222
+6% +$242K 0.61% 33
2025
Q3
$3.73M Buy
20,132
+2,785
+16% +$477K 0.53% 38
2025
Q2
$2.65M Sell
17,347
-2,526
-13% -$388K 0.45% 44
2025
Q1
$3.3M Buy
19,873
+2,683
+16% +$420K 0.56% 34
2024
Q4
$2.49M Buy
17,190
+10
+0.1% +$1.55K 0.42% 47
2024
Q3
$2.78M Buy
17,180
+1,034
+6% +$165K 0.48% 41
2024
Q2
$2.36M Buy
16,146
+1,894
+13% +$282K 0.43% 46
2024
Q1
$2.25M Hold
14,252
0.44% 44
2023
Q4
$2.23M Sell
14,252
-1,179
-8% -$181K 0.46% 40
2023
Q3
$2.4M Hold
15,431
0.55% 32
2023
Q2
$2.55M Sell
15,431
-26
-0.2% -$4.2K 0.54% 30
2023
Q1
$2.4M Sell
15,457
-1,760
-10% -$284K 0.51% 34
2022
Q4
$3.04M Buy
17,217
+207
+1% +$35.7K 0.63% 24
2022
Q3
$2.78M Buy
17,010
+533
+3% +$90.2K 0.64% 26
2022
Q2
$2.92M Buy
16,477
+8
+0% +$1.43K 0.73% 26
2022
Q1
$2.92M Sell
16,469
-3,492
-17% -$594K 0.62% 27
2021
Q4
$3.42M Sell
19,961
-402
-2% -$65.8K 0.65% 26
2021
Q3
$3.29M Buy
20,363
+1,920
+10% +$328K 0.79% 19
2021
Q2
$3.04M Buy
18,443
+28
+0.2% +$4.64K 0.86% 17
2021
Q1
$3.03M Sell
18,415
-93
-0.5% -$15K 0.94% 18
2020
Q4
$2.91M Buy
18,508
+1,066
+6% +$157K 0.87% 18
2020
Q3
$2.6M Buy
17,442
+4
+0% +$592 1.45% 16
2020
Q2
$2.45M Sell
17,438
-386
-2% -$56.3K 1.48% 16
2020
Q1
$2.34M Sell
17,824
-6,948
-28% -$986K 1.54% 18
2019
Q4
$3.61M Buy
24,772
+915
+4% +$124K 1.45% 19
2019
Q3
$3.09M Buy
23,857
+3,394
+17% +$447K 1.33% 24
2019
Q2
$2.85M Sell
20,463
-1,794
-8% -$248K 1.54% 22
2019
Q1
$3.11M Buy
22,257
+160
+0.7% +$21.4K 1.58% 22
2018
Q4
$2.85M Sell
22,097
-3,172
-13% -$442K 1.61% 19
2018
Q3
$3.49M Buy
25,269
+76
+0.3% +$10.1K 1.66% 21
2018
Q2
$3.06M Sell
25,193
-1,000
-4% -$125K 1.52% 20
2018
Q1
$3.36M Buy
26,193
+1,000
+4% +$135K 1.49% 18
2017
Q4
$3.52M Buy
+25,193
New +$3.51M 1.59% 18

Other funds holding JNJ

Biltmore Family Office's JNJ Position: Q2 2026 in Review

Biltmore Family Office reduced its Johnson & Johnson (JNJ) stake by 0.88% in Q2 2026, selling an estimated $43.3K and leaving 20,990 shares worth $5.33M. The position accounts for 0.7% of the portfolio, ranked #33.

Biltmore Family Office first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Biltmore Family Office held 20,990 shares of Johnson & Johnson worth $5.33M as of Q2 2026.
  • Biltmore Family Office sold 186 Johnson & Johnson shares in Q2 2026, an estimated $43.3K.
  • Johnson & Johnson made up 0.7% of Biltmore Family Office's portfolio in Q2 2026, its #33 holding.
  • Biltmore Family Office first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Biltmore Family Office's 13F filing for Q2 2026, filed 12 Aug 2026.